617 serious complications recorded after injection
–
–
Injection for coronavirus infection was given to 90 198 673 Indians. The country uses the vaccines Covishield and Covaxin.
In India, as of the end of March, after vaccination against coronavirus, 617 severe and serious complications occurred, 180 people died. The drugs Covishield and Covaxin are used in the country, writes The Hindu with reference to the National Committee on Side Effects after Immunization (AEFI).
“In India, by the end of last month after immunization from COVID-19, 180 people died. We have begun to study adverse reactions after receiving the Covishield and Covaxin vaccines to identify the causes of such deaths, including due to the formation of rare thrombosis,” the publication quotes words of representatives of AEFI.
To study adverse reactions after immunization, AEFI was recommended by the European Medicines Administration after deaths were recorded in the UK after injections with the drug AstraZeneca, which is produced by the Indian Serum Institute under the Covishield brand.
“Indian regulators must now provide data on any adverse events reported in India,” said Srinath Reddy, President of the India Public Health Foundation.
In India, the population began to vaccinate on January 16. According to the Ministry of Health, as of Friday, April 9, 90,198,673 Indians were vaccinated.
Meanwhile, India has registered the most significant increase in infected for the entire time of the coronavirus epidemic. During the day, 115,736 Indians were infected.
Also Korrespondent.net wrote that in India they called condition for the resumption of export of the AstraZeneca vaccine – only if the epidemic in India itself begins to decline. “We will be forced to continue deliveries to India and nowhere else. Because we have to protect our people,” said the Institute’s executive director Adar Punavalla.
News from Correspondent.net in Telegram. Subscribe to our channel https://t.me/korrespondentnet
– .
